Ana Radeljevic - Net Worth and Insider Trading
Ana Radeljevic Net Worth
The estimated net worth of Ana Radeljevic is at least $61,218 dollars as of 2024-04-28. Ana Radeljevic is the Director of Merrimack Pharmaceuticals Inc and owns about 4,156 shares of Merrimack Pharmaceuticals Inc (MACK) stock worth over $61,218. Details can be seen in Ana Radeljevic's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Ana Radeljevic has not made any transactions after 2023-01-06 and currently still holds the listed stock(s).
Transaction Summary of Ana Radeljevic
Ana Radeljevic Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Ana Radeljevic owns 1 companies in total, including Merrimack Pharmaceuticals Inc (MACK) .
Click here to see the complete history of Ana Radeljevic’s form 4 insider trades.
Insider Ownership Summary of Ana Radeljevic
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| MACK | Merrimack Pharmaceuticals Inc | 2023-01-06 | director |
Ana Radeljevic Latest Holdings Summary
Ana Radeljevic currently owns a total of 1 stock. Ana Radeljevic owns 4,156 shares of Merrimack Pharmaceuticals Inc (MACK) as of January 6, 2023, with a value of $61,218.
Latest Holdings of Ana Radeljevic
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| MACK | Merrimack Pharmaceuticals Inc | 2023-01-06 | 4,156 | 14.73 | 61,218 |
Holding Weightings of Ana Radeljevic
Ana Radeljevic Form 4 Trading Tracker
According to the SEC Form 4 filings, Ana Radeljevic has made a total of 1 transactions in Merrimack Pharmaceuticals Inc (MACK) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Merrimack Pharmaceuticals Inc is the acquisition of 4,156 shares on January 6, 2023, which cost Ana Radeljevic around $49,997.
Insider Trading History of Ana Radeljevic
- 1
Ana Radeljevic Trading Performance
GuruFocus tracks the stock performance after each of Ana Radeljevic's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Ana Radeljevic is 4.25%. GuruFocus also compares Ana Radeljevic's trading performance to market benchmark return within the same time period. The performance of stocks bought by Ana Radeljevic within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Ana Radeljevic's insider trading performs compared to the benchmark.
Performance of Ana Radeljevic
Average Return
10.42%
Outperforming Transactions
100%
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -2.17 | 4.25 | -1 | 10.42 | ||
| Relative Return to S&P 500(%) | -7.72 | -1.14 | -14.26 | -10.17 |
Ana Radeljevic Ownership Network
Ownership Network List of Ana Radeljevic
Ownership Network Relation of Ana Radeljevic
Ana Radeljevic Owned Company Details
What does Merrimack Pharmaceuticals Inc do?
Who are the key executives at Merrimack Pharmaceuticals Inc?
Ana Radeljevic is the director of Merrimack Pharmaceuticals Inc. Other key executives at Merrimack Pharmaceuticals Inc include director & other: See Remarks Eric Andersen , director & President Gary L Crocker , and director & other: See Remarks Noah G. Levy .
Merrimack Pharmaceuticals Inc (MACK) Insider Trades Summary
Over the past 18 months, Ana Radeljevic made 1 insider transaction in Merrimack Pharmaceuticals Inc (MACK) with a net purchase of 4,156. Other recent insider transactions involving Merrimack Pharmaceuticals Inc (MACK) include a net purchase of 942,726 shares made by Eric Andersen , a net purchase of 100,000 shares made by Noah G. Levy , and a net purchase of 4,000 shares made by Gary L Crocker .
In summary, during the past 3 months, insiders sold 0 shares of Merrimack Pharmaceuticals Inc (MACK) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Merrimack Pharmaceuticals Inc (MACK) were sold and 1,050,882 shares were bought by its insiders, resulting in a net purchase of 1,050,882 shares.
Merrimack Pharmaceuticals Inc (MACK)'s detailed insider trading history can be found in Insider Trading Tracker table.
Merrimack Pharmaceuticals Inc Insider Transactions
Ana Radeljevic Mailing Address
Above is the net worth, insider trading, and ownership report for Ana Radeljevic. You might contact Ana Radeljevic via mailing address: 2430 Beacon Street, Unit 201, Chestnut Hill Ma 02467.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
